Cargando…
Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours
BACKROUND: Testicular germ cell tumour (TGCT) is the most common cause of death from solid tumours in young men and especially for platinum-refractory patients novel treatment approaches are urgently needed. Using an in silico screening approach for the detection of novel cancer drugs with inhibitor...
Autores principales: | Nitzsche, B, Gloesenkamp, C, Schrader, M, Ocker, M, Preissner, R, Lein, M, Zakrzewicz, A, Hoffmann, B, Höpfner, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905278/ https://www.ncbi.nlm.nih.gov/pubmed/20551952 http://dx.doi.org/10.1038/sj.bjc.6605725 |
Ejemplares similares
-
Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
por: Nitzsche, B, et al.
Publicado: (2012) -
Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer
por: Steinemann, Gustav, et al.
Publicado: (2019) -
Imaging of testicular germ cell tumours
por: Dalal, P U, et al.
Publicado: (2006) -
Risk of testicular germ-cell tumours in relation to childhood physical activity
por: Cook, M B, et al.
Publicado: (2008) -
Glycolipids of human primary testicular germ cell tumours.
por: Olie, R. A., et al.
Publicado: (1996)